Immunic
IMUX
61 hedge funds and large institutions have $92.4M invested in Immunic in 2024 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 5 closing their positions.
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
49% more capital invested
Capital invested by funds: $62.1M → $92.4M (+$30.3M)
21% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 14
11% more funds holding
Funds holding: 55 → 61 (+6)
0.02% more ownership
Funds ownership: 6.2% → 6.22% (+0.02%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
83% less call options, than puts
Call options by funds: $118K | Put options by funds: $698K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Focus Partners Wealth
Boston,
Massachusetts
|
+$3.05M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.37M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$738K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$607K |
| 5 |
Morgan Stanley
New York
|
+$520K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$2.81M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$907K |
| 3 |
JFG
Jefferies Financial Group
New York
|
-$368K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$321K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$120K |
IMUX Hedge Fund Activity: Q3 2024 in Review
61 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q3 2024, worth a combined $92.4M — up 49% from $62.1M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new IMUX positions and 5 closed out — a net gain of 7 holders — while 17 added to existing stakes and 14 trimmed.
The largest buyer was Focus Partners Wealth, opening a new position worth an estimated $3.05M. The largest seller was Janus Henderson Group, cutting an estimated $2.81M.
- 61 institutional investors held Immunic (IMUX) as of Q3 2024, up from 55 in Q2 2024.
- Funds reported $92.4M of Immunic stock for Q3 2024, up 49% quarter-over-quarter.
- 12 funds opened new Immunic positions in Q3 2024 and 5 closed out, a net change of +7 holders.
- The largest Immunic buyer in Q3 2024 was Focus Partners Wealth, an estimated $3.05M added.
- The largest Immunic seller in Q3 2024 was Janus Henderson Group, an estimated $2.81M sold.
Based on aggregated 13F filings for Q3 2024.